ELTP has a ridiculous amount of shares outstanding. The Chairman is awarded millions very often. This stock, is known for dilution. I sincerely expect a reverse split before the FDA catalyst, which is never a guarantee. Then might try to uplist to a major exchange, in attempt to draw more investors. I expect no less than a 1 for 50 reverse split to try to get to $15 to attract a buyer or institutional investors. Based on their long history of dilution, and sure uncertainty of FDA approval, I tend to tread very lightly with this one. $100 is the max I will invest. This will definitely be very volatile from mid-May thru July. I expect to double that $100 if I can wait till, but the FDA decision could still be before July 14.
Market Data 
Markets 
AI
